Target Group Inc. (CBDY) financial statements (2022 and earlier)
Company profile
Business Address |
55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN, ON L4K-4G9 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
SIC | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |||
---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Current Assets | ||||||||
Cash, cash equivalents, and short-term investments | 173 | 10 | 303 | 0 | 16 | |||
Cash and cash equivalents | 173 | 10 | 303 | 0 | 16 | |||
Receivables | 349 | 41 | 221 | 14 | ||||
Inventory, net of allowances, customer advances and progress billings | 99 | 124 | ||||||
Inventory | 99 | 124 | ||||||
Prepaid expense | 47 | 38 | 35 | 140 | ||||
Advances on inventory purchases | 43 | |||||||
Other undisclosed current assets | 45 | (14) | ||||||
Total current assets: | 755 | 213 | 559 | 0 | 156 | |||
Noncurrent Assets | ||||||||
Operating lease, right-of-use asset | 101 | ✕ | ✕ | ✕ | ||||
Property, plant and equipment | 7,794 | 8,104 | 1 | |||||
Long-term investments and receivables | 721 | |||||||
Long-term investments | 721 | |||||||
Intangible assets, net (including goodwill) | 3,666 | 8,148 | 3,594 | 138 | ||||
Goodwill | 3,666 | 8,148 | 3,594 | |||||
Intangible assets, net (excluding goodwill) | 138 | |||||||
Other noncurrent assets | 31 | |||||||
Other undisclosed noncurrent assets | 2,595 | |||||||
Total noncurrent assets: | 12,282 | 16,252 | 6,222 | 138 | ||||
TOTAL ASSETS: | 13,037 | 16,464 | 6,781 | 0 | 294 | |||
LIABILITIES AND EQUITY | ||||||||
Liabilities | ||||||||
Current Liabilities | ||||||||
Accounts payable and accrued liabilities, including: | 1,809 | 2,495 | 1,740 | 110 | 278 | |||
Accrued liabilities | 1,002 | 2,152 | 68 | 28 | 14 | |||
Interest and dividends payable | 404 | 54 | 133 | |||||
Settlement liabilities | 90 | |||||||
Other undisclosed accounts payable and accrued liabilities | 313 | 289 | 1,538 | 82 | 264 | |||
Deferred revenue | 43 | 43 | ✕ | ✕ | ✕ | |||
Debt | 2 | 78 | 222 | 573 | 702 | |||
Deferred rent credit | 262 | ✕ | ✕ | |||||
Derivative instruments and hedges, liabilities | 12 | 151 | 862 | 952 | 475 | |||
Due to related parties | 2,832 | 782 | 613 | 428 | 659 | |||
Other undisclosed current liabilities | 176 | 1,325 | ||||||
Total current liabilities: | 4,873 | 5,135 | 3,437 | 2,062 | 2,114 | |||
Noncurrent Liabilities | ||||||||
Long-term debt and lease obligation | 1,622 | 48 | ||||||
Long-term debt, excluding current maturities | 48 | |||||||
Operating lease, liability | 1,622 | ✕ | ✕ | ✕ | ||||
Liabilities, other than long-term debt | 10,051 | 1,347 | ||||||
Deferred rent credit | 1,347 | ✕ | ✕ | |||||
Due to related parties | 7,103 | |||||||
Derivative instruments and hedges, liabilities | 2,948 | |||||||
Other undisclosed noncurrent liabilities | 10 | |||||||
Total noncurrent liabilities: | 11,684 | 1,394 | ||||||
Total liabilities: | 16,557 | 6,529 | 3,437 | 2,062 | 2,114 | |||
Stockholders' equity | ||||||||
Stockholders' equity attributable to parent, including: | (3,521) | 9,935 | 3,344 | (2,062) | (1,820) | |||
Preferred stock | 0 | 0 | 0 | 0 | 0 | |||
Common stock | 57 | 57 | 9 | 1 | 4 | |||
Common stock, share subscribed but unissued, subscriptions receivable | (220) | (220) | ||||||
Additional paid in capital | 23,941 | 29,846 | 11,346 | 5,058 | 3,577 | |||
Accumulated other comprehensive loss | (1,175) | (897) | (56) | |||||
Accumulated deficit | (26,536) | (19,463) | (9,095) | (7,195) | (5,452) | |||
Other undisclosed stockholders' equity attributable to parent | 192 | 612 | 1,359 | 73 | 52 | |||
Other undisclosed stockholders' equity | 1 | |||||||
Total stockholders' equity: | (3,520) | 9,935 | 3,344 | (2,062) | (1,820) | |||
TOTAL LIABILITIES AND EQUITY: | 13,037 | 16,464 | 6,781 | 0 | 294 |
Income statement (P&L) ($ in thousands)
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
---|---|---|---|---|---|---|---|
Revenues | 30 | 0 | 15 | 6 | |||
Cost of revenue (Cost of Goods and Services Sold) | (25) | (151) | |||||
Gross profit: | 5 | (151) | 0 | 15 | 6 | ||
Operating expenses | (1,569) | (4,690) | (1,281) | (925) | (1,672) | ||
Operating loss: | (1,564) | (4,841) | (1,281) | (909) | (1,666) | ||
Nonoperating expense | (5,509) | (5,678) | (620) | (0) | (6) | ||
Foreign currency transaction loss, before tax | (168) | (419) | (34) | (0) | (6) | ||
Interest and debt expense | (3,348) | (1,428) | (39) | (104) | (65) | ||
Loss from continuing operations before equity method investments, income taxes: | (10,422) | (11,947) | (1,939) | (1,014) | (1,738) | ||
Other undisclosed income (loss) from continuing operations before income taxes | 3,348 | 1,579 | 39 | (729) | (607) | ||
Net loss available to common stockholders, diluted: | (7,074) | (10,368) | (1,900) | (1,743) | (2,345) |
Comprehensive Income ($ in thousands)
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
---|---|---|---|---|---|---|---|
Net loss: | (7,074) | (10,368) | (1,900) | (1,743) | (2,345) | ||
Comprehensive loss: | (7,074) | (10,368) | (1,900) | (1,743) | (2,345) | ||
Other undisclosed comprehensive loss, net of tax, attributable to parent | (278) | (503) | (56) | ||||
Comprehensive loss, net of tax, attributable to parent: | (7,352) | (10,870) | (1,956) | (1,743) | (2,345) |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.